Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer
  • Seagen
  • Genmab

This publication has 23 references indexed in Scilit: